Gamal Sidarous MD in Phoenix, Arizona

Medical School: Sorry, his university is not listed
Graduation Year: 1978
The Primary Medical Specialty for Gamal Sidarous MD is listed as: Nuclear Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 46
PAC (PECOS ID)#: 0042220063
NPI #: 1699731802
NPI Created On: 04/25/2006
NPI Last Updated Listed as: 05/19/2008
Primary Taxonomy Code: 207U00000X
License Number:
30595
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Health Net of Arizona, Inc.
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Arabic, English.

Services and Procedures include:

1. Nuclear medicine whole body study for thyroid cancer
2. Imaging of liver and bile duct system with use of drugs
3. Stomach emptying study
4. Bone and/or joint imaging, whole body
5. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
6. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
7. Nuclear medicine study of blood circulation in the lungs
8. Nuclear medicine study of lung ventilation and blood circulation in the lungs
9. Nuclear medicine study with measurement of blood circulation in the lungs
10. Nuclear medicine study of kidney with assessment of blood flow and function
11. Spect nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, 1 day of imaging
12. Nuclear medicine study with ct imaging skull base to mid-thigh
13. Spect nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, with concurrently acquired ct transmission scan, 1 day of imaging
14. Oral administration of radioactive material therapy agent
15. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
16. Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring
17. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
18. Technetium tc-99m sestamibi, diagnostic, per study dose
19. Injection, regadenoson, 0.1 mg